Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global pharmaceutical drug delivery market size reached US$ 1,325 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,848 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.

Pharmaceutical drug delivery is a method of administering therapeutic substances into the body. It improves efficiency, safety, and patient experience by controlling the rate, time, and place of drug release. At present, different types of drug delivery systems are available for the release of various therapeutic agents. For instance, gels, liposomes, microspheres, prodrugs, and cyclodextrins are among the effective systems used for peptide and protein therapeutics.

Pharmaceutical Drug Delivery Market Trends:
The growing prevalence of diseases, such as respiratory, leishmaniasis, central nervous system (CNS), and systemic fungal infections, represents one of the key factors bolstering the market growth. Moreover, a significant increase in the number of death rates among the older population and individuals who have cancer is catalyzing the demand for pharmaceutical drug delivery systems. These systems provide enhanced efficacy and reduced toxicity for anticancer agents. The market is also influenced by consumer inclination towards personalized and minimally invasive (MI) medical therapy. Apart from this, nanoparticles composed of biodegradable polymers are gaining popularity for enhancing drug delivery to the brain. They also assist in fulfilling the stringent requirements placed on drug delivery systems by governing agencies of numerous countries. These requirements generally include stability against forces generated during aerosolization, biocompatibility, targeting specific sites or cell populations in the lung, drug release in a predetermined manner, and degradation within an acceptable period. In line with this, researchers are focusing on developing new drug delivery systems, which is contributing to market growth. Furthermore, with the surging cases of coronavirus disease (COVID-19) across the globe, there is a rise in the demand for pharmaceutical drugs, which, in turn, is anticipated to fuel the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical drug delivery market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on route of administration, application and end user.

Breakup by Route of Administration:

Oral Drug Delivery
Injectable Drug Delivery
Topical Drug Delivery
Ocular Drug Delivery
Pulmonary Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Nasal Drug Delivery

Breakup by Application:

Infectious Diseases
Cancer
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Central Nervous System Disorders
Autoimmune Diseases
Others

Breakup by End User:

Hospitals
Ambulatory Surgery Centers
Home Care Settings
Diagnostic Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report:
How has the global pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pharmaceutical drug delivery market?
What are the key regional markets?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pharmaceutical drug delivery market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmaceutical Drug Delivery Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Route of Administration
6.1 Oral Drug Delivery
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Injectable Drug Delivery
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Topical Drug Delivery
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Ocular Drug Delivery
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Pulmonary Drug Delivery
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Implantable Drug Delivery
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Transmucosal Drug Delivery
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Nasal Drug Delivery
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Application
7.1 Infectious Diseases
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cancer
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cardiovascular Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Diabetes
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory Diseases
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Central Nervous System Disorders
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Autoimmune Diseases
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Others
7.8.1 Market Trends
7.8.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgery Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Home Care Settings
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Diagnostic Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 AstraZeneca plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Becton Dickinson and Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 GSK plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Johnson & Johnson
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Novartis AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Pfizer Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Sanofi S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings